Scott Dreyer

Corporate Officer/Principal bei COLLEGIUM PHARMACEUTICAL, INC.

Vermögen: 1 Mio $ am 31.03.2024

52 Jahre

Health Technology

Consumer Services

Aktive Positionen von Scott Dreyer

Unternehmen	Position	Beginn	Ende
COLLEGIUM PHARMACEUTICAL, INC.	Corporate Officer/Principal	10.07.2018	-
COLLEGIUM PHARMACEUTICAL, INC.	Sales & Marketing	01.01.2018	10.07.2018

Unternehmen	Position	Beginn	Ende
THE MEDICINES COMPANY	Sales & Marketing	01.09.2016	01.12.2017
BIOGEN INC.	Sales & Marketing	01.06.2014	01.09.2016
MERCK & CO., INC.	Corporate Officer/Principal	01.01.1994	01.01.2013

University of Messiah

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Sales & Marketing	3
Corporate Officer/Principal	2
Undergraduate Degree	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
MERCK & CO., INC.	Health Technology
BIOGEN INC.	Health Technology
COLLEGIUM PHARMACEUTICAL, INC.	Health Technology

Private Unternehmen	1
The Medicines Co. The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.	Health Technology

Private Unternehmen

Health Technology